image
image
user-login
Patent search/

Advanced Breast Cancer Detection System Using Enhanced Mammographic Analysis

search

Patent Search in India

  • tick

    Extensive patent search conducted by a registered patent agent

  • tick

    Patent search done by experts in under 48hrs

₹999

₹399

Talk to expert

Advanced Breast Cancer Detection System Using Enhanced Mammographic Analysis

ORDINARY APPLICATION

Published

date

Filed on 5 November 2024

Abstract

Breast cancer is the most common ailment among women. Breast cancer cases are growing and rising on a regular basis. An automation system using an AI algorithm is presented to assist the radiologist in the task of evaluating the digital mammography image to discover anomalies associated to breast cancer. Mammogram images are low contrast, however early detection can be aided by improving the medical visual quality of the image with the use of a trained CNN template. Furthermore, a user-friendly Mat-lab-based graphical user interface (GUI) is developed, enabling radiologists to save patient data and produce images for subsequent use on their PCs.

Patent Information

Application ID202441084398
Invention FieldCOMPUTER SCIENCE
Date of Application05/11/2024
Publication Number45/2024

Inventors

NameAddressCountryNationality
V Dhivya BhavaniS.A. Engineering College, Veeraragavapuram, Chennai-77.IndiaIndia
Ardly Melba Reena BS.A. Engineering College, Veeraragavapuram, Chennai-77.IndiaIndia
Nathiya MS.A. Engineering College, Veeraragavapuram, Chennai-77.IndiaIndia

Applicants

NameAddressCountryNationality
V Dhivya BhavaniS.A. Engineering College, Veeraragavapuram, Chennai-77.IndiaIndia
Ardly Melba Reena BS.A. Engineering College, Veeraragavapuram, Chennai-77.IndiaIndia
Nathiya MS.A. Engineering College, Veeraragavapuram, Chennai-77.IndiaIndia
S.A. Engineering CollegeS.A. Engineering College, Veeraragavapuram, Chennai-77.IndiaIndia

Specification

Description:FIELD OF INVENTION
Developing algorithms that analyze mammogram images to detect abnormalities more
accurately than human radiologists. These technologies can help reduce false positives and false
negatives, leading to earlier and more reliable diagnoses. Innovations in imaging technologies, such
as 3D mammography (tomosynthesis), which provide clearer images and improved visualization of
breast tissue, allowing for better detection of tumors. Creating advanced software that enhances the
quality of mammogram images, making it easier to spot subtle changes or lesions. Combining
mammogram images with data from other imaging modalities (like ultrasound or MRI) to provide a
more comprehensive view of breast cancer. Development of devices that can monitor breast health
continuously and alert users to potential issues before they become serious. Platforms that facilitate
remote analysis of mammograms, making expertise accessible in underserved areas and improving
access to timely diagnoses .Innovations that incorporate patient data, such as genetic risk factors or
personal medical history, to create personalized screening and diagnostic plans. Creating simulators
and educational tools that use real mammogram data to train radiologists in identifying signs of
breast cancer.
BACKGROUND OF INVENTION
The most common type of cancer that has a major impact on women's lives is breast cancer.
The second most common cause of cancer-related death among women is breast cancer. The
incidence of breast cancer in women is subject to variation according to age. Global data on breast
cancer reveals that the likelihood of having breast cancer is significantly elevated for around one out
of every eight women aged 70 and above. Early identification significantly improves the prognosis
and survival rates of those diagnosed with breast cancer. Mammography has emerged as a prevalent
imaging modality that has demonstrated utility in the context of breast cancer screening. The
development and implementation of effective breast cancer detection systems that utilize
mammography are crucial for enhancing timely diagnosis and treatment. Mammography use X-ray
technology to generate high-resolution images of breast tissue, facilitating the detection of
abnormalities such as tumors or potentially concerning masses by healthcare practitioners. Although
mammograms have become a customary screening procedure, several variables, including picture
quality, radiologist expertise, and breast tissue density, might impact the precision of detection. More
sophisticated technologies and approaches are therefore required in order to improve the detection
process and lower the number of false positives and false negatives. Mammography remains the
most effective diagnostic modality for detecting breast lesions, particularly among women aged 40
and above. Mammograms are considered to play a vital role in the early identification of breast
cancer due to its ability to identify around 75% of cases up to a year prior to the palpable
manifestation of a lump, as perceived by both the patient and the physician. Numerous studies have
provided evidence indicating that mammography have the potential to decrease the mortality rate of
women aged 50 and above by approximately 35%. Breast cancer is a major public health concern on
a global scale. The prompt diagnosis of medical conditions is necessary to improve patient outcomes.
The subset of artificial intelligence known as deep learning has exhibited promising outcomes. Deep
learning models have shown to be valuable instruments in the analysis of intricate medical images
due to their exceptional ability to extract intricate patterns from extensive datasets. The main goal of
this research is to develop and put into use a sophisticated framework that uses artificial intelligence
and machine learning techniques to accurately identify breast cancer from mammography analysis.
METHODOLOGY OF INVENTION
The principal objective of formulating a breast cancer detection system is to create a
dependable and highly responsive instrument that can support radiologists in discerning dubious
regions in mammograms, thereby facilitating timely diagnosis. The process entails extracting various
characteristics from mammographic images including but not limited to shape, texture, and density
patterns. These extracted features are then subjected to analysis and classification using machine
learning or deep learning algorithms The primary objective of establishing a robust and accurate
breast cancer detection system is to augment the abilities of healthcare professionals, optimize the
effectiveness of breast cancer screening programs, and eventually contribute to improved patient
outcomes. The continuous refining and validation of these systems play a critical role in
guaranteeing their dependability and efficacy in real-world clinical environments. This section
provides an introduction to the building of pre-trained models and their utilization in tasks related to
breast cancer named entity recognition. The creation process of the cancer graph detection utilizing
the named entity identification method the suggested system is categorized into three distinct phases.
In the initial phase, the picture and input image were subjected to pre-processing, wherein undesired
data and outcomes were eliminated.
At the level of de-noising, it serves the purpose of eliminating noise or undesired artifacts
present in the loaded image. After that, the image is converted from the RGB colour space to the
grayscale colour space, which more faithfully captures the original colour composition of the image.
It has been discovered that applying pre-processing methods improves the precision of breast cancer
identification when using mammography images. When an image is used as input, the process of
image resizing is employed to guarantee that all images possess uniform proportions. This practice
facilitates the creation of a consistent dataset for analysis, encompassing normalization and contrast
enhancement techniques that boost the visibility of significant characteristics.
Fig. 1. breast cancer detection system
During the segmentation phase, the algorithm identifies and isolates the region of interest by
distinguishing it from the backdrop. The utilization of image registration facilitates the alignment of
many photographs of a single patient acquired at different time points, hence enhancing the potential
for comprehensive comparative analysis. The concept of ROI (region of interest) pertains to the
selective identification of specific sections within an image that are of particular relevance, such as
the affected region or the entirety of the breast cancer area. This approach aims to enhance the
algorithm's efficiency by narrowing its emphasis to relevant parts. The filtering technique is
employed to selectively highlight specific qualities or eliminate noise and extraneous information. In
order to increase the size of the current data set, the process of data augmentation entails creating
synthetic data through the application of various transformations. The process of quality control
involves assessing the quality of mammography images, hence eliminating low-quality or unusable
images from the dataset. The utilization of image enhancement techniques has been shown to be
beneficial in enhancing the quality of mammography images, hence aiding in the identification of
breast cancer. The enhancement of these images can facilitate the identification of anomalies in
images by radiologists and computer-aided detection (CAD) systems.
The boosting method incorporates intensity windowing techniques to selectively assign
intensity levels for the purpose of highlighting tissue structures and anomalies. Text enhancement
techniques include a range of texture filters that can be employed to enhance the appearance of
textures and patterns that are linked to irregularities or anomalies. Adaptive filtering techniques are
made to change their parameters dynamically based on an image's local characteristics. ROI
enhancement aims to increase visibility by applying enhancement techniques to specific regions of
interest. The process of image fusion involves the integration of pictures obtained from various
modalities, such as mammography and ultrasound, with the objective of incorporating
complementary information that can be beneficial for diagnostic purposes. The deep learning-based
enhancement technique use a deep neural network to acquire enhancement techniques directly from
the available data. The Bi-dimensional Empirical Mode Decomposition (BEMD)technique is
employed for the purpose of eliminating background noise and extracting direct waves. The
suggested filtering approach effectively eliminates both high and low- frequency sounds. Statistical
analysis involves the collection of data or images for the purpose of analyzing substantial amounts of
information in order to observe the process of data processing. Upon conducting an analysis of the
statistical data, the image or data is statistics in order to examine the association between the
presence or likelihood of breast cancer. In the medical domain, professionals are able to discern risk
factors in mammography images, which are utilized as input for analysis. This analysis aids
researchers in tracking the progression of breast cancer. When it comes to breast cancer, correlation
statistics are one part of a wide range of instruments and approaches used to understand the
complexities of the illness and develop improved approaches to treatment, early detection, and
prevention. Following the conclusion of the breast cancer study, the proposed diagnosis represents a
crucial stage in the locating and confirming the presence of breast cancer in specific datasets. The
process of illness diagnosis encompasses the integration of assessment, which entails the
examination of medical history encompassing symptomatology, familial cancer history, and prior
breast health concerns. In certain instances, magnetic resonance imaging (MRI) may be employed to
conduct a more comprehensive assessment of breast irregularities, particularly when mammography
or ultrasound findings are definitive or for patients with a heightened risk profile. During the process
of pathological investigation, tissue samples acquired during biopsy are forwarded to a pathologist
who conducts a microscopic analysis of the specimens. Pathologists possess the ability to validate
the existence of cancer and furnish comprehensive insights into its distinctive attributes. Upon the
completion of all diagnostic tests, a multidisciplinary team of healthcare specialists such as
oncologists, surgeons, radiologists, and pathologists will convene to deliberate on the diagnosis and
propose an optimal treatment strategy. Based on the condition's staging and diagnosis, a treatment
plan is created. Treatment options for breast cancer can include surgery, radiation therapy,
chemotherapy, hormone therapy, and targeted therapy, depending on the specific characteristics of
the cancer. Patient education and support services aim to impart knowledge regarding the diagnosis,
available treatment modalities, and potential adverse effects. It is imperative to acknowledge that
timely detection plays a pivotal role in achieving improved outcomes in cases of breast cancer. It is
encouraged to engage in regular breast self-examinations, have clinical breast examinations, and
participate in mammography screening as means of early detection. The utilization of imaging
techniques in mammography serves as a valuable tool for the purpose of screening and diagnosing
various conditions. Initially, the process entails the utilization of X-ray imaging to identify the
presence of breast tissues, including tumors or calcification, which can be discerned by
mammography. The timely identification and precise assessment of breast cancer are of utmost
importance in effectively addressing the disease and enhancing patient prognosis. Upon reaching the
last stage, the outcome of the diagnostic process will be presented. A formal document that is
typically issued to patients by healthcare professionals, such as oncologists or surgeons. The purpose
of this diagnostic report is to convey the results of the cancer investigation and ascertain the presence
of breast cancer. This report concludes the phase of breast cancer that denotes the magnitude of the
ailment. It is imperative for patients to acquire a comprehensive comprehension of their breast cancer
diagnosis and treatment plan. The provision of assistance from a healthcare team, as well as the
establishment of an emotional support system, assumes paramount importance in facilitating patients'
navigation through the trajectory of breast cancer. The process of diagnosing a medical condition
often entails a comprehensive assessment that incorporates clinical evaluation, imaging techniques,
and examination of pathology results. The healthcare professional will communicate to the patient
that the diagnostic tests and biopsies have shown conclusive evidence indicating the existence of
breast cancer. The diagnosis will delineate the specific subtype of breast cancer, and medical
professionals will engage in a comprehensive discussion regarding the stage of the aforementioned
malignancy. The staging of cancer is determined by the degree of metastasis, with a classification
system consisting of stages ranging from one to four.
The evaluation of a breast cancer detection system, specifically built for the analysis of
mammograms commonly involves the assessment of multiple performance indicators in order to
gauge the system's accuracy and dependability. The True Positive Rate is a metric that quantifies the
system's capacity to accurately detect true positive instances, specifically referring to cases in which
breast cancer is present. A high sensitivity level indicates the system's ability to recognize and detect
positive cases. The True Negative Rate measures the system's ability to correctly identify negative
cases-those in which breast cancer is not detected. A high specificity indicates that false positive
results are effectively reduced by the system. Generally speaking, accuracy is a metric that expresses
the proportion of cases-true positives and true negatives-that area accurately classified in relation
to the total number of cases that were evaluated. A high degree of accuracy must be attained for the
system to be considered dependable.
Fig. 2. Precision for Breast Cancer Detection
The curve representing the receiver operating characteristic (ROC) provides a visual
representation of the ratio of specificity to sensitivity. Better performance is indicated by a higher
AUC value. The ratio of correctly identified positive cases to the total number of positive forecasts is
known as the Positive Predictive Value, or PPV. This metric shows the probability that a positive
prediction will materialize. The negative predictive value, or NPV, is the ratio of correctly identified
true negative cases to the total number of negative predictions. This metric expresses the probability
that a negative prediction will materialize. Create a dataset with images of breast cancer and labels
indicating whether the condition is malignant or benign. In order to attain a consistent and
standardized size, photos must be resized. Choose a deep learning framework such as TensorFlow or
pyTorch. Convolutional Neural Networks (CNNs) can be employed in the utilization of pre-trained
models such as VGG16 and ResNet, or in the creation of a customized CNN architecture. The
chosen deep learning framework is used to implement the model architecture. Kindly furnish the
model's evaluation metric, optimizer, and loss function details. Binary cross-entropy is the loss
function used for binary classification. Adam is the optimizer that is being used, and accuracy is the
selected evaluation metric. The fit function is used to enter the training data into the model. In order
to minimize the risk of overfitting and evaluate the model's performance during training, the
validation data should be used. Use the test dataset to evaluate the trained model's performance. The
custom classification head is included in the deep learning technique VGG16 model, which is used
for feature extraction. VGG16's convolutional layers are immobilized to maintain the information
learned during pre-training. The breast cancer dataset is used in the model's construction and training. , Claims:Both VGG16 and ResNet50 leverage deep learning architectures that can capture complex
patterns in mammogram images, potentially leading to higher accuracy in detecting
malignancies.
2. These models can help distinguish between benign and malignant lesions more effectively,
reducing unnecessary biopsies and missed cancers. Automated detection can save time for
radiologists, allowing them to focus on cases that require more nuanced interpretation.
3. Utilizing pre-trained versions of these models on large datasets allows for effective finetuning
on mammogram datasets, leading to better performance with less training data.
4. These algorithms can incorporate techniques like data augmentation, helping improve model
robustness by exposing it to various image conditions (e.g., different lighting, angles).
Integration with patient data can help tailor screening recommendations based on individual
risk factors, improving early detection rates.
5. These algorithms can be integrated into existing radiology workflows, enhancing overall
diagnostic processes and ensuring that mammography is part of a comprehensive cancer
detection strategy.

Documents

NameDate
202441084398-COMPLETE SPECIFICATION [05-11-2024(online)].pdf05/11/2024
202441084398-DECLARATION OF INVENTORSHIP (FORM 5) [05-11-2024(online)].pdf05/11/2024
202441084398-DRAWINGS [05-11-2024(online)].pdf05/11/2024
202441084398-EDUCATIONAL INSTITUTION(S) [05-11-2024(online)].pdf05/11/2024
202441084398-EVIDENCE FOR REGISTRATION UNDER SSI(FORM-28) [05-11-2024(online)].pdf05/11/2024
202441084398-FORM 1 [05-11-2024(online)].pdf05/11/2024
202441084398-FORM FOR SMALL ENTITY(FORM-28) [05-11-2024(online)].pdf05/11/2024
202441084398-FORM-9 [05-11-2024(online)].pdf05/11/2024
202441084398-REQUEST FOR EARLY PUBLICATION(FORM-9) [05-11-2024(online)].pdf05/11/2024

footer-service

By continuing past this page, you agree to our Terms of Service,Cookie PolicyPrivacy Policy  and  Refund Policy  © - Uber9 Business Process Services Private Limited. All rights reserved.

Uber9 Business Process Services Private Limited, CIN - U74900TN2014PTC098414, GSTIN - 33AABCU7650C1ZM, Registered Office Address - F-97, Newry Shreya Apartments Anna Nagar East, Chennai, Tamil Nadu 600102, India.

Please note that we are a facilitating platform enabling access to reliable professionals. We are not a law firm and do not provide legal services ourselves. The information on this website is for the purpose of knowledge only and should not be relied upon as legal advice or opinion.